The federal government is currently not seeking approval of the AstraZeneca vaccine. Government spokesman Steffen Seibert emphasized the safety of the vaccine. There are reservations about the vaccine among the general public.
The federal government rejects the demand of Bavaria’s Prime Minister Markus Söder (CSU) back that vaccine from AstraZeneca should be shared with everyone. Government spokesman Steffen Seibert also emphasized that there are very different reasons why not all vaccine doses have been inoculated.
Seibert said that there had already been a “certain degree of flexibility” because “educators, teachers and daycare workers” had been upgraded in the prioritization. “But a general release at this point in time is not something the federal government is pursuing,” said Seibert.
General practitioners’ practices should only be allowed to vaccinate AstraZeneca vaccines if enough vaccine is available
The Ministry of Health said there were enough people in the priority groups who should and would like to be vaccinated first. The spokesman for the Ministry of Health, Sebastian Gülde, said that approval could only be discussed when “sufficient vaccine is available”. Then it could be thought about “going into the field” with the vaccine and also having it inoculated in general practitioners’ practices.
Berlin’s Governing Mayor Michael Müller (SPD) had previously called for an immediate change to the vaccination ordinance. “Against the background of the increasing number of infections, we must not lose any more time,” said Müller to the “Tagesspiegel”. The federal government should adjust the vaccination ordinance “this week” if possible, “so that medical practices can offer vaccinations earlier, especially for the chronically ill.”
The federal government emphasized the effectiveness of the AstraZeneca vaccine. According to Seibert, the government indicates “at every opportunity” that the AstraZeneca vaccine “has been properly approved”. Citizens could “trust” that it is “a safe and effective vaccine,” said Seibert.
In whole Germany vaccination appointments remain unused if the AstraZeneca vaccine is to be administered, which is also due to the fact that the Standing Vaccination Commission has only approved the vaccine from the age of 65. There have been reports of lesser effectiveness as well alleged side effects.
Objectively speaking, the AstraZeneca vaccine is very good at slowing the pandemic. The summary results of the pivotal studies showed that the vaccine was 60 percent effective after two doses. That sounds like little, especially in comparison to Biontech and Moderna, which came to around 95 percent. However, the percentage does not indicate how many people the vaccine will work in and how many will not. It describes by what percentage the risk of vaccinated people to contract Covid-19 falls compared to unvaccinated people.
EU commissioner warns of gap between delivered and inoculated vaccines
I-Commissioner Stella Kyriakides has meanwhile urged Germany and the other member states to rapidly expand their corona vaccination campaigns. It is “crucial that there is no gap between the doses delivered and the doses administered and that no vaccines go unused,” said Kyriakides on Monday at an online conference of EU health ministers.
The EU Commission itself was sharply criticized because initially too little vaccine was available. However, the delivery volumes are expected to increase, especially in the second quarter. Kyriakides said the vaccination campaign needs to keep pace with the growing amounts of vaccine. “We have to vaccinate as soon as possible, especially since the new virus variants come into play,” said the commissioner.